To identify new genetic modifiers for epidermolysis bullosa simplex (EBS), a team led by scientists at Tel Aviv Medical Center performed exome sequencing of 195 patients with EBS from 90 different ...

STATEN ISLAND, N.Y. — A fundraising Polar Plunge to honor John Hudson Dilgen will take place this month in South Beach to ...

But if we’re going to defend public health, we have to identify its real enemies, and there’s a difference between a Texas ...

The European Medicines Agency’s (EMA) human medicines committee has recommended Krystal Biotech’s Vyjuvek (beremagene ...

Sam Schulz, a 20-year-old with Epidermolysis Bullosa, has developed a close friendship with Ole Miss basketball coach Chris ...

The winner of the annual series between the Padres and Mariners will now win the Vedder Cup, a trophy designed by Pearl Jam ...

Jefferies analyst Roger Song initiated coverage of Krystal Biotech (KRYS) with a Buy rating and $245 price target Krystal is a commercial ...

The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB105, which is in Phase 1/2 clinical trials ...

Sam Schulz, a 20-year-old with Epidermolysis Bullosa, has developed a close friendship with Ole Miss basketball coach Chris Beard. Schulz, who is a big basketball fan, has become an inspiration to ...

Oppenheimer initiated coverage of Abeona Therapeutics (ABEO) with an Outperform rating and $16 price target The company’s main value driver is ...

Bulwark+ Takes brings you bite-sized takes on the news of the day from the entire Bulwark team. This is the home to ad-free video shorts, Bulwark+ member-only livestreams, and live event archives. The ...